|
|
News Breaks | | | | January 23, 2013 | | 10:13 EDT |  | DGX | Quest Diagnostics gaps down, spikes lower, after earnings
The stock was last down over 6.5% which is off the lows of the session. The company reported earnings of $1.01 per share versus consensus of $1.02 for its Q4. It is guidance which is taking the shares down, which was reduced to a range of $4.35 to $4.55 for its fiscal year 2013 versus consensus of $4.81. At the current price of $57.66, support is at $57.11. a recent pivot low on the daily chart. Resistance is at $58, today's opening price. | |
|
News For DGX From The Last 14 Days Check below for free stories on DGX the last two weeks. |
|
|
| May 16, 2013 | | 10:10 EDT |  | DGX | Quest Diagnostics Humana acquires Concentra's laboratory business
 Subscribe for More Information | | | May 15, 2013 | | 17:30 EDT | | DGX | Relational Investors gives quarterly update on stakes
Subscribe for More Information | | | May 10, 2013 | | 14:43 EDT |  | DGX | Proposed reimbursement rates positive for LabCorp, Quest, says Piper Jaffray
Subscribe for More Information | | | May 9, 2013 | | 19:21 EDT |  | DGX | Better days ahead for Quest Diagnostics, Barron's says
Quest Diagnostics, which is up 3.5% over the last 12 months, making it one of the worst performing health care stocks in the S&P 500, is also one of the cheapest names in that index at 12 times 2014 earnings, and better days are ahead for the stock, says Barron's Weekday Trader. Reference Link | |
|
|
|
|
|
|
